The Legacy of 'Star Trek': William Shatner Discusses Real-World Innovations
May 30, 2025 - 03:07
Long before the advent of modern smartphones and advanced computing, Captain Kirk was already utilizing futuristic communicators and other cutting-edge technology in the beloved series "Star Trek." In an engaging conversation with Al Roker, William Shatner, the actor who brought the iconic character to life, reflects on his book "I'm Working on That: A Trek From Science Fiction to Science Fact."
Shatner expresses his admiration for the remarkable advancements in technology that have emerged, many of which were initially envisioned in the series. He emphasizes the profound impact that "Star Trek" has had on inspiring real-world scientific innovations, showcasing how fiction can often pave the way for future realities.
As he discusses the connections between the show's imaginative concepts and actual technological developments, Shatner's enthusiasm for the future shines through. His insights serve as a reminder of the power of creativity in shaping our understanding of what is possible in the realm of science and technology.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...